{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:44:36Z","timestamp":1792583076689,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The work was supported by the state assignment"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-026-02615-9","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:20:45Z","timestamp":1792581645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The GBA1-related variant rs12411216 is Associated with Motor and Non-Motor Impairments and Unfavorable Progression in Parkinson\u2019s Disease: A Five-Year Longitudinal Study"],"prefix":"10.1007","volume":"76","author":[{"given":"Elena","family":"Bragina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nikitina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Skorikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Shipulina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Alifirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nazarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"1","key":"2615_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"1","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 1(1):47. https:\/\/doi.org\/10.1038\/s41572-021-00280-3","journal-title":"Nat Rev Dis Primers"},{"key":"2615_CR2","doi-asserted-by":"publisher","first-page":"1538472","DOI":"10.3389\/fmolb.2025.1538472","volume":"12","author":"Y Asadi","year":"2025","unstructured":"Asadi Y, Moundounga RK, Chakroborty A, Pokokiri A, Wang H (2025) FOXOs and their roles in acute and chronic neurological disorders. Front Mol Biosci 12:1538472. https:\/\/doi.org\/10.3389\/fmolb.2025.1538472","journal-title":"Front Mol Biosci"},{"issue":"12","key":"2615_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/mds.27864","volume":"34","author":"S Bandres-Ciga","year":"2019","unstructured":"Bandres-Ciga S, Ahmed S, Sabir MS, Blauwendraat C, Adarmes-G\u00f3mez AD, Bernal-Bernal I, Bonilla-Toribio M, Buiza-Rueda D, Carrillo F, Carri\u00f3n-Claro M, G\u00f3mez-Garre P, Jes\u00fas S, Labrador-Espinosa MA, Macias D, M\u00e9ndez-Del-Barrio C, Peri\u00f1\u00e1n-Tocino T, Tejera-Parrado C, Vargas-Gonz\u00e1lez L, Diez-Fairen M, Alvarez I, Tartari JP, Buongiorno M, Aguilar M, Gorostidi A, Bergareche JA, Mondragon E, Vinagre-Aragon A, Croitoru I, Ruiz-Mart\u00ednez J, Dols-Icardo O, Kulisevsky J, Mar\u00edn-Lahoz J, Pagonabarraga J, Pascual-Sedano B, Ezquerra M, C\u00e1mara A, Compta Y, Fern\u00e1ndez M, Fern\u00e1ndez-Santiago R, Mu\u00f1oz E, Tolosa E, Valldeoriola F, Gonzalez-Aramburu I, Sanchez Rodriguez A, Sierra M, Men\u00e9ndez-Gonz\u00e1lez M, Blazquez M, Garcia C, Suarez-San Martin E, Garc\u00eda-Ruiz P, Mart\u00ednez-Castrillo JC, Vela-Desojo L, Ruz C, Barrero FJ, Escamilla-Sevilla F, M\u00ednguez-Castellanos A, Cerdan D, Tabernero C, Gomez Heredia MJ, Perez Errazquin F, Romero-Acebal M, Feliz C, Lopez-Sendon JL, Mata M, Mart\u00ednez Torres I, Kim JJ, Dalgard CL, Brooks J, Saez-Atienzar S, Gibbs JR, Jorda R, Botia JA, Bonet-Ponce L, Morrison KE, Clarke C, Tan M, Morris H, Edsall C, Hernandez D, Simon-Sanchez J, Nalls MA, Scholz SW, Jimenez-Escrig A, Duarte J, Vives F, Duran R, Hoenicka J, Alvarez V, Infante J, Marti MJ, Clarim\u00f3n J, L\u00f3pez de Munain A, Pastor P, Mir P, Singleton A, International Parkinson Disease Genomics Consortium (2019) The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight. Mov Disord 34(12):1851\u20131863. https:\/\/doi.org\/10.1002\/mds.27864","journal-title":"Mov Disord"},{"issue":"9","key":"2615_CR4","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gr.137323.112","volume":"22","author":"AP Boyle","year":"2012","unstructured":"Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, Cherry JM, Snyder M (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 22(9):1790\u20131797. https:\/\/doi.org\/10.1101\/gr.137323.112","journal-title":"Genome Res"},{"issue":"10","key":"2615_CR5","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang D, Nalls MA, Hallgr\u00edmsd\u00f3ttir IB, Hunkapiller J, van der Brug M, Cai F, International Parkinson\u2019s Disease Genomics Consortium; 23andMe Research Team, Kerchner GA, Ayalon G, Bingol B, Sheng M, Hinds D, Behrens TW, Singleton AB, Bhangale TR, Graham RR (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat Genet 49(10):1511\u20131516. https:\/\/doi.org\/10.1038\/ng.3955","journal-title":"Nat Genet"},{"issue":"3","key":"2615_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical Excellence (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5(3):235\u2013245. https:\/\/doi.org\/10.1016\/S1474-4422(06)70373-8","journal-title":"Lancet Neurol"},{"issue":"2","key":"2615_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s43587-024-00760-7","volume":"5","author":"EG Chew","year":"2025","unstructured":"Chew EG, Liu Z, Li Z, Chung SJ, Lian MM, Tandiono M, Heng YJ, Ng EY, Tan LC, Chng WL, Tan TJ, Peh EK, Ho YS, Chen XY, Lim EY, Chang CH, Leong JJ, Peh TX, Chan LL, Chao Y, Au WL, Prakash KM, Lim JL, Tay YW, Mok V, Chan AY, Lin JJ, Jeon BS, Song K, Tham CC, Pang CP, Ahn J, Park KH, Wiggs JL, Aung T, Tan AH, Ahmad Annuar A, Makarious MB, Blauwendraat C, Nalls MA, Robak LA, Alcalay RN, Gan-Or Z, Reynolds R, Lim SY, Xia Y, Khor CC, Tan EK, Wang Z, Foo JN (2025) Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson\u2019s disease risk. Nat Aging 5(2):205\u2013218. https:\/\/doi.org\/10.1038\/s43587-024-00760-7","journal-title":"Nat Aging"},{"issue":"1","key":"2615_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/acn3.371","volume":"4","author":"CA Cooper","year":"2016","unstructured":"Cooper CA, Jain N, Gallagher MD, Weintraub D, Xie SX, Berlyand Y, Espay AJ, Quinn J, Edwards KL, Montine T, Van Deerlin VM, Trojanowski J, Zabetian CP, Chen-Plotkin AS (2016) Common variant rs356182 near SNCA defines a Parkinson\u2019s disease endophenotype. Ann Clin Transl Neurol 4(1):15\u201325. https:\/\/doi.org\/10.1002\/acn3.371","journal-title":"Ann Clin Transl Neurol"},{"key":"2615_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/bs.ircmb.2016.08.010","volume":"329","author":"N Cremades","year":"2017","unstructured":"Cremades N, Chen SW, Dobson CM (2017) Structural Characteristics of \u03b1-Synuclein Oligomers. Int Rev Cell Mol Biol 329:79\u2013143. https:\/\/doi.org\/10.1016\/bs.ircmb.2016.08.010","journal-title":"Int Rev Cell Mol Biol"},{"key":"2615_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.expneurol.2014.05.025","volume":"261","author":"AR Esteves","year":"2014","unstructured":"Esteves AR, Swerdlow RH, Cardoso SM (2014) LRRK2, a puzzling protein: insights into Parkinson\u2019s disease pathogenesis. Exp Neurol 261:206\u2013216. https:\/\/doi.org\/10.1016\/j.expneurol.2014.05.025","journal-title":"Exp Neurol"},{"issue":"1","key":"2615_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41531-022-00307-w","volume":"8","author":"SL Farrow","year":"2022","unstructured":"Farrow SL, Cooper AA, O\u2019Sullivan JM (2022) Redefining the hypotheses driving Parkinson\u2019s diseases research. NPJ Parkinson\u2019s disease 8(1):45. https:\/\/doi.org\/10.1038\/s41531-022-00307-w","journal-title":"NPJ Parkinson\u2019s disease"},{"issue":"8","key":"2615_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11910-018-0860-4","volume":"18","author":"Z Gan-Or","year":"2018","unstructured":"Gan-Or Z, Liong C, Alcalay RN (2018) GBA-Associated Parkinson\u2019s Disease and Other Synucleinopathies. Curr Neurol Neurosci Rep 18(8):44. https:\/\/doi.org\/10.1007\/s11910-018-0860-4","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5493","key":"2615_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.290.5493.985","volume":"290","author":"BI Giasson","year":"2000","unstructured":"Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290(5493):985\u2013989. https:\/\/doi.org\/10.1126\/science.290.5493.985","journal-title":"Science"},{"issue":"s1","key":"2615_CR14","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JPD-179005","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert M, Jakes R, Spillantini MG (2017) The Synucleinopathies: Twenty Years On. J Parkinsons Dis 7(s1):S51\u2013S69. https:\/\/doi.org\/10.3233\/JPD-179005","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"2615_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/15384101.2019.1577666","volume":"18","author":"DH Ho","year":"2019","unstructured":"Ho DH, Seol W, Son I (2019) Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of \u03b1-synuclein. Cell Cycle 18(4):467\u2013475. https:\/\/doi.org\/10.1080\/15384101.2019.1577666","journal-title":"Cell Cycle"},{"issue":"1","key":"2615_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13041-020-00637-x","volume":"13","author":"Z Jiang","year":"2020","unstructured":"Jiang Z, Huang Y, Zhang P, Han C, Lu Y, Mo Z, Zhang Z, Li X, Zhao S, Cai F, Huang L, Chen C, Shi Z, Zhang Y, Ling F (2020) Characterization of a pathogenic variant in GBA for Parkinson\u2019s disease with mild cognitive impairment patients. Mol Brain 13(1):102. https:\/\/doi.org\/10.1186\/s13041-020-00637-x","journal-title":"Mol Brain"},{"issue":"9996","key":"2615_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"issue":"1","key":"2615_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/life12010121","volume":"12","author":"K Kolarikova","year":"2022","unstructured":"Kolarikova K, Vodicka R, Vrtel R, Stellmachova J, Prochazka M, Mensikova K, Bartonikova T, Furst T, Kanovsky P, Geryk J (2022) High-Throughput Sequencing Haplotype Analysis Indicates in LRRK2 Gene a Potential Risk Factor for Endemic Parkinsonism in Southeastern Moravia, Czech Republic. Life (Basel) 12(1):121. https:\/\/doi.org\/10.3390\/life12010121","journal-title":"Life (Basel)"},{"issue":"7","key":"2615_CR19","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/biomedicines13071624","volume":"13","author":"C Koros","year":"2025","unstructured":"Koros C, Stanitsa E, Angelopoulou E, Papageorgiou SG, Stefanis L (2025) Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background. Biomedicines 13(7):1624. https:\/\/doi.org\/10.3390\/biomedicines13071624","journal-title":"Biomedicines"},{"issue":"6","key":"2615_CR20","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/brain\/awy077","volume":"141","author":"E Kozina","year":"2018","unstructured":"Kozina E, Sadasivan S, Jiao Y, Dou Y, Ma Z, Tan H, Kodali K, Shaw T, Peng J, Smeyne RJ (2018) Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. Brain 141(6):1753\u20131769. https:\/\/doi.org\/10.1093\/brain\/awy077","journal-title":"Brain"},{"key":"2615_CR21","doi-asserted-by":"publisher","first-page":"1424561","DOI":"10.3389\/fnmol.2024.1424561","volume":"17","author":"QQ Liu","year":"2024","unstructured":"Liu QQ, Wu GH, Wang XC, Xiong XW, Rui-Wang, Yao BL (2024) The role of Foxo3a in neuron-mediated cognitive impairment. Front Mol Neurosci 17:1424561. https:\/\/doi.org\/10.3389\/fnmol.2024.1424561","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2615_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13041-019-0504-x","volume":"12","author":"BR Malik","year":"2019","unstructured":"Malik BR, Maddison DC, Smith GA, Peters OM (2019) Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Mol Brain 12(1):100. https:\/\/doi.org\/10.1186\/s13041-019-0504-x","journal-title":"Mol Brain"},{"key":"2615_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fnins.2020.00527","volume":"14","author":"A Marchand","year":"2020","unstructured":"Marchand A, Drouyer M, Sarchione A, Chartier-Harlin MC, Taymans JM (2020) LRRK2 Phosphorylation, More Than an Epiphenomenon. Front Neurosci Jun 14:527. https:\/\/doi.org\/10.3389\/fnins.2020.00527","journal-title":"Front Neurosci Jun"},{"issue":"14","key":"2615_CR24","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/mds.25226","volume":"27","author":"IF Mata","year":"2012","unstructured":"Mata IF, Checkoway H, Hutter CM, Samii A, Roberts JW, Kim HM, Agarwal P, Alvarez V, Ribacoba R, Pastor P, Lorenzo-Betancor O, Infante J, Sierra M, G\u00f3mez-Garre P, Mir P, Ritz B, Rhodes SL, Colcher A, Van Deerlin V, Chung KA, Quinn JF, Yearout D, Martinez E, Farin FM, Wan JY, Edwards KL, Zabetian CP (2012) Common variation in the LRRK2 gene is a risk factor for Parkinson\u2019s disease. Mov Disord 27(14):1822\u20131825. https:\/\/doi.org\/10.1002\/mds.25226","journal-title":"Mov Disord"},{"issue":"1","key":"2615_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/mds.26359","volume":"31","author":"IF Mata","year":"2016","unstructured":"Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, Bernard B, Espay AJ, Revilla FJ, Devoto J, Rosenthal LS, Dawson TM, Albert MS, Tsuang D, Huston H, Yearout D, Hu SC, Cholerton BA, Montine TJ, Edwards KL, Zabetian CP (2016) GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson\u2019s disease. Mov Disord 31(1):95\u2013102. https:\/\/doi.org\/10.1002\/mds.26359","journal-title":"Mov Disord"},{"issue":"13","key":"2615_CR26","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.3390\/ijms26136001","volume":"26","author":"R Mohammadi","year":"2025","unstructured":"Mohammadi R, Shirazi M, Sadat-Madani SF, Yeo Cheng Long MZ, Singh CL, Tan JY, Deng X, Hashemi Fard SM, Ng SYE, Ng ASL, Tan LCS, Saffari SE (2025) Common SNCA Genetic Variants and Parkinson\u2019s Disease Risk: A Systematic Review and Meta-Analysis. Int J Mol Sci 26(13):6001. https:\/\/doi.org\/10.3390\/ijms26136001","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2615_CR28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB, Alzheimer Genetic Analysis Group (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet 46(9):989\u2013993. https:\/\/doi.org\/10.1038\/ng.3043","journal-title":"Nat Genet"},{"issue":"12","key":"2615_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, Bras J, Young E, von Coelln R, Sim\u00f3n-S\u00e1nchez J, Schulte C, Sharma M, Krohn L, Pihlstr\u00f8m L, Siitonen A, Iwaki H, Leonard H, Faghri F, Gibbs JR, Hernandez DG, Scholz SW, Botia JA, Martinez M, Corvol JC, Lesage S, Jankovic J, Shulman LM, Sutherland M, Tienari P, Majamaa K, Toft M, Andreassen OA, Bangale T, Brice A, Yang J, Gan-Or Z, Gasser T, Heutink P, Shulman JM, Wood NW, Hinds DA, Hardy JA, Morris HR, Gratten J, Visscher PM, Graham RR, Singleton AB (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12):1091\u20131102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5. 23andMe Research Team; System Genomics of Parkinson\u2019s Disease Consortium; International Parkinson\u2019s Disease Genomics Consortium","journal-title":"Lancet Neurol"},{"issue":"47","key":"2615_CR29","doi-asserted-by":"publisher","first-page":"11366","DOI":"10.1523\/JNEUROSCI.0964-17.2017","volume":"37","author":"PY Pan","year":"2017","unstructured":"Pan PY, Li X, Wang J, Powell J, Wang Q, Zhang Y, Chen Z, Wicinski B, Hof P, Ryan TA, Yue Z (2017) Parkinson\u2019s Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons. J Neurosci 37(47):11366\u201311376. https:\/\/doi.org\/10.1523\/JNEUROSCI.0964-17.2017","journal-title":"J Neurosci"},{"issue":"1","key":"2615_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41531-021-00196-5","volume":"7","author":"CC Pedersen","year":"2021","unstructured":"Pedersen CC, Lange J, F\u00f8rland MGG, Macleod AD, Alves G, Maple-Gr\u00f8dem J (2021) A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson\u2019s disease. NPJ Parkinsons Dis 7(1):54. https:\/\/doi.org\/10.1038\/s41531-021-00196-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"2615_CR31","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"2615_CR32","doi-asserted-by":"publisher","first-page":"889802","DOI":"10.3389\/fnins.2022.889802","volume":"16","author":"J Prahl","year":"2022","unstructured":"Prahl J, Coetzee GA (2022) Genetic Elements at the Alpha-Synuclein Locus. Front Neurosci 16:889802. https:\/\/doi.org\/10.3389\/fnins.2022.889802","journal-title":"Front Neurosci"},{"issue":"1","key":"2615_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/ddac161","volume":"32","author":"JD Prahl","year":"2023","unstructured":"Prahl JD, Pierce SE, van der Schans EJC, Coetzee GA, Tyson T (2023) The Parkinson\u2019s disease variant rs356182 regulates neuronal differentiation independently from alpha-synuclein. Hum Mol Genet 32(1):1\u201314. https:\/\/doi.org\/10.1093\/hmg\/ddac161","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2615_CR34","doi-asserted-by":"publisher","first-page":"e13504","DOI":"10.1111\/acel.13504","volume":"20","author":"F Rey","year":"2021","unstructured":"Rey F, Pandini C, Messa L, Launi R, Barzaghini B, Zangaglia R, Raimondi MT, Gagliardi S, Cereda C, Zuccotti GV, Carelli S (2021) \u03b1-Synuclein antisense transcript SNCA-AS1 regulates synapses- and aging-related genes suggesting its implication in Parkinson\u2019s disease. Aging Cell 20(12):e13504. https:\/\/doi.org\/10.1111\/acel.13504","journal-title":"Aging Cell"},{"key":"2615_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.11.015","volume":"73","author":"K Senkevich","year":"2020","unstructured":"Senkevich K, Gan-Or Z (2020) Autophagy lysosomal pathway dysfunction in Parkinson\u2019s disease; evidence from human genetics. Parkinsonism Relat Disord 73:60\u201371. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.11.015","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2615_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1134\/S0006297923030100","volume":"88","author":"MI Shadrina","year":"2023","unstructured":"Shadrina MI, Slominsky PA (2023) Genetic Architecture of Parkinson\u2019s Disease. Biochem (Mosc) 88(3):417\u2013433. https:\/\/doi.org\/10.1134\/S0006297923030100","journal-title":"Biochem (Mosc)"},{"issue":"17","key":"2615_CR37","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, D\u00fcrr A, Eblan MJ, Fahn S, Farrer MJ, Fung HC, Gan-Or Z, Gasser T, Gershoni-Baruch R, Giladi N, Griffith A, Gurevich T, Januario C, Kropp P, Lang AE, Lee-Chen GJ, Lesage S, Marder K, Mata IF, Mirelman A, Mitsui J, Mizuta I, Nicoletti G, Oliveira C, Ottman R, Orr-Urtreger A, Pereira LV, Quattrone A, Rogaeva E, Rolfs A, Rosenbaum H, Rozenberg R, Samii A, Samaddar T, Schulte C, Sharma M, Singleton A, Spitz M, Tan EK, Tayebi N, Toda T, Troiano AR, Tsuji S, Wittstock M, Wolfsberg TG, Wu YR, Zabetian CP, Zhao Y, Ziegler SG (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361(17):1651\u20131661. https:\/\/doi.org\/10.1056\/NEJMoa0901281","journal-title":"N Engl J Med"},{"issue":"7601","key":"2615_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature17939","volume":"533","author":"F Soldner","year":"2016","unstructured":"Soldner F, Stelzer Y, Shivalila CS, Abraham BJ, Latourelle JC, Barrasa MI, Goldmann J, Myers RH, Young RA, Jaenisch R (2016) Parkinson-associated risk variant in distal enhancer of \u03b1-synuclein modulates target gene expression. Nature 533(7601):95\u201399. https:\/\/doi.org\/10.1038\/nature17939","journal-title":"Nature"},{"issue":"11","key":"2615_CR39","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95(11):6469\u20136473. https:\/\/doi.org\/10.1073\/pnas.95.11.6469","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2615_CR40","doi-asserted-by":"publisher","unstructured":"Szwedo AA, Dalen I, Pedersen KF, Camacho M, B\u00e4ckstr\u00f6m D, Forsgren L, Tzoulis C, Winder-Rhodes S, Hudson G, Liu G, Scherzer CR, Lawson RA, Yarnall AJ, Williams-Gray CH, Macleod AD, Counsell CE, Tysnes OB, Alves G, Maple-Gr\u00f8dem J Parkinson\u2019s Incidence Cohorts Collaboration (2022) GBA and APOE impact cognitive decline in parkinson\u2019s disease: A 10-year population-based study. Mov Disord 37(5):1016\u20131027. https:\/\/doi.org\/10.1002\/mds.28932","DOI":"10.1002\/mds.28932"},{"issue":"35","key":"2615_CR41","doi-asserted-by":"publisher","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L (2008) Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 283(35):23542\u201323556. https:\/\/doi.org\/10.1074\/jbc.M801992200","journal-title":"J Biol Chem"},{"key":"2615_CR42","doi-asserted-by":"publisher","unstructured":"Wan J, Pan H, Chang D, Zhao Y, Xu Q, Yao L, Sun Q, Zhang X, He R, Wang C, Zhang H, Lei L, Wang Y, Li M, Wu H, Ma J, Wu Y, Xu Y, Xiong N, Wang T, Wang X, Chen L, Xu Y, Cao H, Zhang K, Liu W, Zhang Y, Mao C, Wang Q, Xue Z, Zhang Z, Cheng O, Huang W, Zhao G, Cui G, Chen T, Wang P, Di W, Liu H, Zheng H, Chen C, Guo H, Xia K, Zhang Z, Yuan K, Li J, Wang J, Guo J, Shen L, Jiang H, Liu C, Liu J, Chan P, Liu Z, Tang B Parkinson\u2019s Disease & Movement Disorders Multicenter Database and Collaborative Network in China (PD-MDCNC); China Essential Tremor Alliance (CETA) (2026) The genetic spectrum of LRRK2 variants in Parkinson\u2019s disease: findings from a large Chinese cohort. NPJ Parkinsons Dis 12(1):122. https:\/\/doi.org\/10.1038\/s41531-026-01315-w","DOI":"10.1038\/s41531-026-01315-w"},{"issue":"2","key":"2615_CR43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","volume":"80","author":"D Weintraub","year":"2013","unstructured":"Weintraub D, Papay K, Siderowf A, Parkinson\u2019s Progression Markers Initiative (2013) Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study. Neurology 80(2):176\u2013180. https:\/\/doi.org\/10.1212\/WNL.0b013e31827b915c","journal-title":"Neurology"},{"issue":"7","key":"2615_CR44","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/mds.26170","volume":"30","author":"D Weintraub","year":"2015","unstructured":"Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA (2015) Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson\u2019s disease. Mov Disord 30(7):919\u2013927. https:\/\/doi.org\/10.1002\/mds.26170. Parkinson\u2019s Progression Markers Initiative","journal-title":"Mov Disord"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02615-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-026-02615-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02615-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:20:46Z","timestamp":1792581646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-026-02615-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2615"],"URL":"https:\/\/doi.org\/10.1007\/s12031-026-02615-9","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Siberian State Medical University of the Ministry of Health of the Russian Federation (Protocol No. 7813, May 27, 2019).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"155"}}